Europe Protein A Resin Market: By Product Type (Natural Protein A Resin and Recombinant Protein A Resin), By Matrix Type (Glass or Silica, Agarose, and Organic Polymer), By Application (Immunoprecipitation (IP) and Antibody Purification), By End User (Biopharmaceutical Companies, Clinical Research Laboratories, and Academic Institutes), and Country (Germany, France, U.K, Italy, Spain, Russia, Poland, and Rest of Europe)  

Europe Protein A Resin Market size was valued at USD 131.9 billion in 2022 and is expected to reach USD 262.8 billion by 2029, at a CAGR of 9.0% from 2023-2029. Protein Large volumes of pure materials are processed using resin chromatography in order to detect minute amounts of product contamination. In recent years, chromatography has been a popular method for improving the resin's capacity for the chromatography purification process. It eliminates biochemical combinations based on antigen-antibody, receptor-nucleic acid interaction, and enzyme-substrate interactions. The market for protein A resin is expanding as a result of rising therapeutic antibody production and rising biosimilar demand. Several public and corporate organizations are financing research into proteins to improve medicinal techniques. One of the key elements anticipated to drive the protein resin market is the rising funding and spending for protein-based research. The introduction of novel monoclonal antibodies is anticipated to present companies in the worldwide protein A resin market with lucrative potential prospects. p16 INK4a, a new mouse monoclonal antibody, was introduced by Biocare Medical, LLC in September 2019 for in vitro diagnostic usage in the qualitative identification of the p16 INK4a protein by immunohistochemistry in formalin-fixed paraffin-embedded human tissues.